Loading...
NPI 1437158730 · Madisonville, KY · Pharmacy
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Bluegrass Pharmacies, Inc is a pharmacy provider located in Madisonville, Kentucky. This profile covers 8 Medicare and 8 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Bluegrass Pharmacies, Inc |
| Address | 1128 N Main St |
| City | Madisonville |
| State | KY |
| ZIP | 42431 |
| Taxonomy | Pharmacy |
| NPI Enumerated | July 19, 2005 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $62K |
| Medicaid | $0 |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
8 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 190 | $130 | $24.1K |
| 90662 | This code represents a flu vaccine product that is a split virus type, contains no preservatives, and has enhanced effectiveness due to a higher antigen content. It is administered as an injection… | 160 | $70 | $11.7K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 240 | $40 | $9K |
| 91322 | This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 50 mcg/0.5 mL. | 50 | $140 | $7.2K |
| G0008 | Administration of influenza virus vaccine | 200 | $30 | $5.7K |
| 0124A | N/A | 80 | $40 | $3.1K |
| 0134A | N/A | 20 | $40 | $910 |
| G0009 | Administration of pneumococcal vaccine | 10 | $30 | $290 |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 8 CPT/HCPCS codes.
View: State1 / 2
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
8 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 0003A | N/A | 50 | $0 | $0 |
| 0004A | N/A | 30 | $0 | $0 |
| 0124A | N/A | 40 | $0 | $0 |
| 888888 | N/A | 40 | $0 | $0 |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 60 | $0 | $0 |
| 90688 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It uses split virus technology and is given as a 0.5 mL dose. | 10 | $0 | $0 |
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 90 | $0 | $0 |
| G0008 | Administration of influenza virus vaccine | 30 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other Kentucky providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Kentucky median
8 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 23 | 60 | 30 | $20 | $2.6K |
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 9 | 30 | 20 | $40 | $2.5K |
| 90688 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It uses split virus technology and is given as a 0.5 mL dose. | 260 | 290 | 70 | $10 | $2.1K |
| 0004A | N/A | 45 | 70 | 30 | $20 | $1.9K |
| 0003A | N/A | 21 | 50 | 50 | $10 | $1.6K |
| 0124A | N/A | 22 | 50 | 40 | $20 | $1.4K |
| G0008 | Administration of influenza virus vaccine | 171 | 310 | 30 | $10 | $570 |
| 888888 | N/A | 76 | 120 | 70 | $0 | $0 |
Other providers in the same ZIP code as Bluegrass Pharmacies, Inc, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Baptist Health Deaconess Madisonville Inc | KY | Rural Acute Care Hospital | $0 | $80.8M |
| Caris Counseling & Behavioral Health Group | KY | Professional Counselor | $0 | $8.1M |
| Baptist Health Deaconess Medical Group Inc | KY | Internal Medicine Physician | $0 | $5.2M |
| Medical Center Ambulance Service Inc | KY | Land Ambulance | $745.8K | $1.2M |
| Owensboro Health Medical Group, Inc | KY | Clinical Medical Laboratory | $42.2K | $478.6K |
| Deepak Kapadia | KY | Cardiovascular Disease Physician | $225.1K | $180.7K |
| Ashwani Kumar | KY | Hospitalist Physician | $290.5K | $200 |
| Robert Holzknecht | KY | Family Medicine Physician | $217.1K | $0 |
| Henry Smith | KY | Plastic and Reconstructive Surgery Physician | $186.8K | $0 |
| William Smith | KY | Dermatology Physician | $174.6K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.